7.82
Fulcrum Therapeutics Inc Aktie (FULC) Neueste Nachrichten
What drives Fulcrum Therapeutics Inc. stock priceFree Investment Portfolio Suggestions - Autocar Professional
What analysts say about Fulcrum Therapeutics Inc. stockFree Stock Selection - Autocar Professional
Fulcrum Therapeutics Inc. Stock Analysis and ForecastAccelerated earnings growth - jammulinksnews.com
Is Fulcrum Therapeutics Inc. a good long term investmentHigh-yield growth strategies - jammulinksnews.com
why fulcrum therapeutics inc. stock attracts strong analyst attentionWeekly Double Return List - Newser
What makes Fulcrum Therapeutics Inc. stock price move sharplyMarket Ready Callouts - Newser
Why Fulcrum Therapeutics Inc. stock attracts strong analyst attentionShort Term Risk Controlled Alerts - Newser
How Fulcrum Therapeutics Inc. stock performs during market volatilitySafe High Return Entry Points - Newser
Fulcrum Therapeutics (FULC) Drops 2.25% Despite 3.25% Intraday Gain - AInvest
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Fulcrum Therapeutics Awards Major Stock Options Package Worth $912,600 to Strategic New Hire - Stock Titan
Fulcrum Therapeutics (FULC) Soars 14.31% on Earnings Report - AInvest
Fulcrum Therapeutics (NASDAQ:FULC) investors are sitting on a loss of 60% if they invested five years ago - Yahoo Finance
Fulcrum Therapeutics Elects New Directors at Annual Meeting - TipRanks
Is Fulcrum Therapeutics, Inc. overvalued or undervalued? - MarketsMojo
Cantor Fitzgerald Reaffirms Their Buy Rating on Fulcrum Therapeutics (FULC) - The Globe and Mail
Bank of America Corp DE Has $432,000 Stock Position in Fulcrum Therapeutics, Inc. (NASDAQ:FULC) - Defense World
Research Analysts Issue Forecasts for FULC FY2026 Earnings - Defense World
Citadel Advisors LLC Makes New $69,000 Investment in Lisata Therapeutics, Inc. (NASDAQ:LSTA) - Defense World
Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Shares Acquired by Millennium Management LLC - Defense World
Comparing Fulcrum Therapeutics (NASDAQ:FULC) and Lakeshore Biopharma (NASDAQ:LSB) - Defense World
Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Shares Sold by Two Sigma Investments LP - Defense World
Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | FULC Stock News - GuruFocus
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule - MarketScreener
Fulcrum Therapeutics Awards Major Stock Options Package: 70,000 Shares at $6.96 Exercise Price - Stock Titan
Fulcrum Therapeutics, Inc. (FULC): A Bull Case Theory - MSN
BNP Paribas Financial Markets Makes New Investment in Fulcrum Therapeutics, Inc. (NASDAQ:FULC) - Defense World
Fulcrum Therapeutics (NASDAQ:FULC) shareholders are up 16% this past week, but still in the red over the last five years - simplywall.st
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):